home / stock / mbrx / mbrx short
Short Information | Moleculin Biotech Inc. (NASDAQ:MBRX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 94,729 |
Total Actual Volume | 495,275 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 4,736 |
Average Short Percentage | 18.42% |
Is there a MBRX Short Squeeze or Breakout about to happen?
See the MBRX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-26-2024 | $4.5 | $4.63 | $4.8966 | $4.405 | 23,885 | 7,713 | 32.29% |
04-25-2024 | $4.3 | $4.3082 | $4.4999 | $4.28 | 22,596 | 6,618 | 29.29% |
04-24-2024 | $4.46 | $4.35 | $4.622 | $4.35 | 7,365 | 1,426 | 19.36% |
04-23-2024 | $4.29 | $4.6 | $4.6 | $4.29 | 7,385 | 1,268 | 17.17% |
04-22-2024 | $4.78 | $4.3 | $4.78 | $4.3 | 16,771 | 602 | 3.59% |
04-19-2024 | $4.59 | $4.65 | $4.66 | $4.4001 | 10,562 | 1,454 | 13.77% |
04-18-2024 | $4.49 | $4.5235 | $5 | $4.41 | 49,640 | 9,123 | 18.38% |
04-17-2024 | $4.32 | $4.28 | $4.4199 | $4.28 | 10,408 | 1,857 | 17.84% |
04-16-2024 | $4.55 | $4.28 | $4.7399 | $4.28 | 15,943 | 4,177 | 26.2% |
04-15-2024 | $4.6 | $4.46 | $4.66 | $4.32 | 20,009 | 3,009 | 15.04% |
04-12-2024 | $4.82 | $4.6269 | $4.97 | $4.54 | 18,602 | 1,718 | 9.24% |
04-11-2024 | $5.06 | $4.77 | $5.1299 | $4.65 | 27,798 | 2,123 | 7.64% |
04-10-2024 | $5.69 | $5.2 | $5.91 | $4.81 | 31,145 | 2,424 | 7.78% |
04-09-2024 | $5.09 | $5.23 | $5.2899 | $5.02 | 22,165 | 3,840 | 17.32% |
04-08-2024 | $5.12 | $5.05 | $5.3399 | $5 | 53,147 | 7,447 | 14.01% |
04-05-2024 | $4.96 | $5.2 | $5.5 | $4.96 | 39,769 | 9,750 | 24.52% |
04-04-2024 | $5.29 | $5.3 | $5.31 | $5.05 | 15,757 | 2,730 | 17.33% |
04-03-2024 | $5.33 | $5.25 | $5.6299 | $5.09 | 46,587 | 14,237 | 30.56% |
04-02-2024 | $5.7 | $5.45 | $5.7 | $5.18 | 28,686 | 8,737 | 30.46% |
04-01-2024 | $5.79 | $5.67 | $6.09 | $5.67 | 27,055 | 4,476 | 16.54% |
News, Short Squeeze, Breakout and More Instantly...
Moleculin Biotech Inc. Company Name:
MBRX Stock Symbol:
NASDAQ Market:
Moleculin Biotech Inc. Website:
Moleculin CEO, Walter Klemp highlights Annamycin differentiation in the current AML treatment landscape and potential opportunity FRENCHTOWN, NJ / ACCESSWIRE / April 25, 2024 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Vir...
European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML) PR Newswire – Next-generation non-cardiotoxic anthracycline Annamycin with notable signs of clinical efficacy in AML in combination with Cytarabine a...
Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties PR Newswire Annamycin demonstrated to be a more potent inhibitor of topoisomerase II-alpha and II-beta while remaining inactive against establi...